We found that 77% of these samples were positive for PIM2 expression (Figure 1F and Figure S1), and that the trend was largely maintained in the most common PTCL subtypes, with a slight predominance in the AITL subtype (Figure 1G). This evidence concerns the gene PIM2 and angioimmunoblastic T-cell lymphoma.